Sign in
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia
Fluorescein Angiographic Evaluation of Peripheral Retinal Vasculature After Ranubizumab Injection for Type I Retinopathy of Prematurity
Clio Armitage Harper, MD
Annual Meeting Talks
2016
Category: Vitreomacular Traction